Search Orphan Drug Designations and Approvals
-
Generic Name: | eflornithine plus sulindac |
---|---|
Date Designated: | 01/22/2013 |
Orphan Designation: | Treatment of familial adenomatous polyposis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Panbela Therapeutics, Inc. 712 Vista Blvd #305 Waconia, Minnesota 55387 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-